Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sylvamo (SLVM) Liabilities and Shareholders Equity (2020 - 2025)

Sylvamo (SLVM) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $2.8 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 6.11% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $10.8 billion, changed 0.03%, while the annual FY2025 figure was $2.8 billion, 6.11% up from the prior year.
  • Liabilities and Shareholders Equity reached $2.8 billion in Q4 2025 per SLVM's latest filing, up from $2.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.9 billion in Q4 2023 and bottomed at $2.6 billion in Q4 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $2.7 billion, with a median of $2.7 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 10.79% in 2021, then grew 6.11% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.6 billion in 2021, then rose by 4.35% to $2.7 billion in 2022, then rose by 5.98% to $2.9 billion in 2023, then dropped by 9.33% to $2.6 billion in 2024, then increased by 6.11% to $2.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $2.8 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.7 billion in Q2 2025.